Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENACITY phase 2 study of AL101 monotherapy in Notch-activated triple-negative breast cancer
MOH_2020-10-13_009155Phase 2Recruiting
- Sponsor
- Ayala Pharmaceuticals, Inc.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of osugacestat, sponsored by Ayala Pharmaceuticals, Inc. Started Aug 2020; status: recruiting.
02
Drugs
osugacestat
Beyond the preview
Go deeper on MOH_2020-10-13_009155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-10-13_009155.